Back to Search Start Over

Effect of speech therapy on quality of life in patients with spinocerebelar ataxia type 3.

Authors :
Diaféria G
Bommarito S
Braga Neto P
Park SW
Padovani M
Haddad F
Haddad L
Voos MC
Chien HF
Pedroso JL
Barsottini O
Source :
Arquivos de neuro-psiquiatria [Arq Neuropsiquiatr] 2022 Oct; Vol. 80 (10), pp. 1017-1025. Date of Electronic Publication: 2022 Dec 19.
Publication Year :
2022

Abstract

Background: Individuals with spinocerebellar ataxia type 3 (SCA3) present communication and swallowing disorders, and consequent deterioration in quality of life (QOL).<br />Objective: To evaluate the impact of a speech therapy rehabilitation program on the QOL of patients with SCA3.<br />Methods: All participants were randomly assigned to two groups, an intervention group receiving speech therapy (STG) and a control group (CG). The International Cooperative Ataxia Rating Scale scores were 32.4 ± 20.2, and the Scale for the Assessment and Rating of Ataxia scores were 11.8 ± 8.0. The intervention consisted of a 12-session speech therapy rehabilitation program with oral, pharyngeal, and laryngeal strengthening exercises-the so-called ATAXIA-Myofunctional Orofacial and Vocal Therapy (A-MOVT). They all were submitted to pre- and postintervention evaluations using the World Health Organization's Quality of Life (WHOQOL-BREF) assessment, as well as the Living with Dysarthria (LwD), Quality of Life in Swallowing Disorders (SWAL-QOL), and Food Assessment Tool (EAT-10).<br />Results: The study sample consisted of 48 patients with SCA3 (STG = 25; CG = 23), mean age was 47.1 ± 11.4 years; mean age at symptom onset was 36.9 ± 11.3 years; disease duration was 11.9 ± 13.3 years. After the 3-month intervention, there were significant changes in the QOL in the STG compared with the CG, when assessed by the LwD (179.12 ± 62.55 vs. 129.88 ± 51.42, p  < 0.001), SWAL-QOL (869.43 ± 153.63 vs. 911.60 ± 130.90, p  = 0.010), and EAT-10 (5.16 ± 7.55 vs. 2.08 ± 3.85, p  = 0.018).<br />Conclusions: Patients with SCA3 should receive continuous speech therapy as part of the A-MOVT program, because therapy helps to improve difficulty swallowing and dysarthria.<br />Competing Interests: The authors have no conflict of interests to declare.<br /> (Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)

Details

Language :
English
ISSN :
1678-4227
Volume :
80
Issue :
10
Database :
MEDLINE
Journal :
Arquivos de neuro-psiquiatria
Publication Type :
Academic Journal
Accession number :
36535286
Full Text :
https://doi.org/10.1055/s-0042-1755203